Shares of Recursion Pharmaceuticals (NASDAQ: RXRX) fell this week. The stock lost 24% as of market close on Friday. The move comes as the S&P 500 and Nasdaq Composite both slipped slightly.

The results of a recent survey released Tuesday showed President Trump's actions are likely to make it harder for biotech companies like Recursion to raise capital. The company reported less-than ...

It continues to draw limited revenue, while its costs are growing notably. For the quarter, Recursion -- which although a clinical-stage company earns some coin from collaboration agreements with ...

Evidently in the mood for some spring cleaning, Salt Lake City’s Recursion is clearing out a chunk of its pipeline as it narrows its focus on R&D in oncology and rare diseases. The move comes ...

Kyiv, Ukraine and Salt Lake City, UT, April 09, 2025 (GLOBE NEWSWIRE) -- Recursion (NASDAQ: RXRX), a leading clinical stage TechBio company decoding biology to radically improve lives, today ...

In this article, we are going to take a look at where Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) stands against other firms that kick off Monday leading gains. The stock market kicked off the ...

SEC commissioner Greg Sankey confirmed Monday that he’s in favor of his conference going to a nine-game football schedule. That declaration, the furthest Sankey has seemed to go publicly ...

That was the case for Recursion Pharmaceuticals, a now publicly traded company that applies artificial intelligence to drug discovery and development. With layoffs at the NIH underway and its ...

NEW ORLEANS, La. — SEC commissioner Greg Sankey, one of the architects of the current College Football Playoff format, is “absolutely” interested in tweaking the format for the 2025 season ...

Kirby Smart roasted Greg Sankey after Georgia's SEC championship victory when he should have thanked the commissioner for a schedule that prepared the Bulldogs for the playoff. Georgia forged its ...

You can reach Allison on Signal at AllisonDeAngelis.01. Recursion Pharmaceuticals, one of the most advanced companies using artificial intelligence and machine learning tools to expedite drug ...